DXS International (AQSE:DXSP) EBIT: £-0.13 Mil (TTM As of Apr. 2025)


What is DXS International EBIT?

DXS International AQSE:DXSP EBIT is £-0.13 Mil as of Apr. 2025. The stock has 2 warning signs investors should review.

DXS International's earnings before interest and taxes (EBIT) for the six months ended in Apr. 2025 was £-0.13 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Apr. 2025 was £-0.13 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. DXS International's annualized ROC % for the quarter that ended in Apr. 2025 was -3.29%. DXS International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2025 was -37.03%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. DXS International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Apr. 2025 was -15.08%.

DXS International  (AQSE:DXSP) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

DXS International's annualized ROC % for the quarter that ended in Apr. 2025 is calculated as:

ROC % (Q: Apr. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Apr. 2024 ) + Invested Capital (Q: Apr. 2025 ))/ count )
=-0.129 * ( 1 - 45.71% )/( (2.316 + 1.937)/ 2 )
=-0.0700341/2.1265
=-3.29 %

where

Invested Capital(Q: Apr. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2.661 - 0.255 - ( 0.09 - max(0, 0.811 - 1.205+0.09))
=2.316

Invested Capital(Q: Apr. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2.371 - 0.427 - ( 0.429 - max(0, 0.909 - 0.916+0.429))
=1.937

Note: The Operating Income data used here is one times the annual (Apr. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

DXS International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Apr. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Apr. 2024  Q: Apr. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.127/( ( (0.001 + max(0.685, 0)) + (0 + max(-0.237, 0)) )/ 2 )
=-0.127/( ( 0.686 + 0 )/ 2 )
=-0.127/0.343
=-37.03 %

where Working Capital is:

Working Capital(Q: Apr. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.811 + 0 + 0.256) - (0.255 + 0 + 0.127)
=0.685

Working Capital(Q: Apr. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.321 + 0 + 0.085) - (0.427 + 0 + 0.216)
=-0.237

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Apr. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

DXS International's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Apr. 2025 )
=-0.127/0.842
=-15.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DXS International EBIT Related Terms

DXS International EBIT Historical Data

* Premium members only.

The historical data trend for DXS International's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DXS International EBIT Chart

DXS International Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 -0.06 -0.04 -4.88 -0.13

DXS International Semi-Annual Data
Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.30 -0.06 -0.04 -4.88 -0.13

AQSE:DXSP vs VEEV, BTSG, TEM: EBIT Comparison

For the Health Information Services subindustry, DXS International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DXS International EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DXS International's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where DXS International's EV-to-EBIT falls into.


DXS International EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Apr. 2025 was £-0.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of £-0.13 Mil mean?
DXS International (AQSE:DXSP) has a EBIT of £-0.13 Mil as of Apr. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on DXS International.
Is DXS International's EBIT too high?
DXS International's current EBIT is £-0.13 Mil.
How does DXS International's EBIT compare to VEEV and BTSG?
DXS International's EBIT of £-0.13 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on DXS International. DXS International's current EBIT is £-0.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
Based on GuruFocus' analysis, DXS International (AQSE:DXSP) is currently considered Possible Value Trap. The stock's GF Value™ is £0.02, compared to a current price of £0.01 — trading 37.5% below its estimated fair value. The current EBIT is £-0.13 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For DXS International (AQSE:DXSP), the current EBIT is £-0.13 Mil as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DXS International Business Description

Address 119 Saint Mary’s Road, Market Harborough, London, Leicestershire, GBR, LE16 7DT
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.